Vanguard Group Inc. Lowers Holdings in Select Medical Holdings Corporation $SEM

Vanguard Group Inc. trimmed its holdings in Select Medical Holdings Corporation (NYSE:SEM) by 0.8% in the 4th quarter, HoldingsChannel reports. The fund owned 12,477,780 shares of the health services provider’s stock after selling 94,378 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Select Medical worth $185,295,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Universal Beteiligungs und Servicegesellschaft mbH boosted its position in shares of Select Medical by 9.7% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider’s stock worth $171,000 after buying an additional 1,014 shares during the period. First Horizon Corp purchased a new position in Select Medical in the fourth quarter valued at $52,000. State of Alaska Department of Revenue boosted its holdings in Select Medical by 1.5% in the fourth quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider’s stock valued at $940,000 after purchasing an additional 935 shares during the period. Sivik Global Healthcare LLC boosted its holdings in Select Medical by 8.6% in the fourth quarter. Sivik Global Healthcare LLC now owns 190,000 shares of the health services provider’s stock valued at $2,822,000 after purchasing an additional 15,000 shares during the period. Finally, Linden Thomas Advisory Services LLC boosted its holdings in Select Medical by 3.7% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 60,911 shares of the health services provider’s stock valued at $905,000 after purchasing an additional 2,145 shares during the period. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on SEM. Wall Street Zen downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Finally, Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, February 20th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Select Medical currently has a consensus rating of “Hold” and an average target price of $15.63.

Select Medical Stock Performance

SEM opened at $16.42 on Monday. The stock has a market cap of $2.04 billion, a P/E ratio of 15.49, a P/E/G ratio of 0.94 and a beta of 1.02. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15. The stock’s 50 day simple moving average is $16.23 and its 200 day simple moving average is $15.31. Select Medical Holdings Corporation has a 1-year low of $11.65 and a 1-year high of $16.99.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The business’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.44 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, equities analysts anticipate that Select Medical Holdings Corporation will post 1.27 EPS for the current fiscal year.

Select Medical declared that its Board of Directors has authorized a share repurchase program on Thursday, February 19th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to buy up to 49.5% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be paid a $0.0625 dividend. The ex-dividend date of this dividend is Thursday, May 14th. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. Select Medical’s dividend payout ratio is presently 23.58%.

Select Medical Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.